Patient-Ventilator Interaction During Noninvasive Ventilation in Subjects With Exacerbation of COPD: Effect of Support Level and Ventilator Mode

Eline Oppersma, Jonne Doorduin, Lisanne H Roesthuis, Johannes G van der Hoeven, Peter H Veltink, Leo Ma Heunks, Eline Oppersma, Jonne Doorduin, Lisanne H Roesthuis, Johannes G van der Hoeven, Peter H Veltink, Leo Ma Heunks

Abstract

Background: Patient-ventilator synchrony in patients with COPD is at risk during noninvasive ventilation (NIV). NIV in neurally-adjusted ventilatory assist (NAVA) mode improves synchrony compared to pressure support ventilation (PSV). The current study investigated patient-ventilator interaction at 2 levels of NAVA and PSV mode in subjects with COPD exacerbation.

Methods: NIV was randomly applied at 2 levels (5 and 15 cm H2O) of PSV and NAVA. Patient-ventilator interaction was evaluated by comparing airway pressure and electrical activity of the diaphragm waveforms with automated computer algorithms.

Results: 8 subjects were included. Trigger delay was longer in PSV high (268 ± 112 ms) than in PSV low (161 ± 118 ms, P = .043), and trigger delay during NAVA was shorter than PSV for both low support (49 ± 24 ms for NAVA, P = .035) and high support (79 ± 276 ms for NAVA, P = .003). No difference in cycling error for low and high levels of PSV (PSV low -100 ± 114 ms and PSV high 56 ± 315 ms) or NAVA (NAVA low -5 ± 18 ms, NAVA high 12 ± 36 ms) and no difference between PSV and NAVA was found.

Conclusions: Increasing PSV levels during NIV caused a progressive mismatch between neural effort and pneumatic timing. Patient-ventilator interaction during NAVA was more synchronous than during PSV, independent of inspiratory support level. (ClinicalTrials.gov registration NCT01791335.).

Keywords: COPD; NAVA; noninvasive ventilation; patient-ventilator asynchrony.

Conflict of interest statement

Dr Heunks has disclosed relationships with Maquet Critical Care, Orion Pharma, and Liberate Medical. The other authors have disclosed no conflicts of interest.

Copyright © 2020 by Daedalus Enterprises.

Source: PubMed

3
Abonnere